To the best of our knowledge, the current report is the first to demonstrate increased plasma level FGF-23 to be independently associated with increased SMI-assessed IPN, an essential sign of plaque instability in a population with carotid atherosclerosis. This evidence concerns the gene FGF23 and bile duct papillary neoplasm.